The technology used in the HoMedics BPA-300, to measure blood pressure, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Legacy approval||Older clinical validation; older protocol|
|ESH (Europe)||Self-measurement||Published evidence|
Yarows SA. Accuracy of the HoMedics BPA-300, a home blood pressure monitor using the auscultatory method. Blood Press Monit. 2007 Oct;12(5):339-43. PMID: 17890974.
SP10:1996 - Pass General population
Grim CE, Grim CM. The HoMedics BPA-200 and BPA-300 home blood pressure devices fail the European Society of Hypertension International Protocol and cannot be recommended for patient use. Blood Press Monit. 2008 Aug;13(4):227-9. doi: 10.1097/MBP.0b013e3282feebf7. PMID: 18635979.
ESH-IP:2002 - Fail General population (Note: Failed SBP and DBP)
Grim C. Problems with the AAMI study of the HoMedics BPA-300 recently published by Yarows. Blood Press Monit. 2008 Aug;13(4):237-8. doi: 10.1097/MBP.0b013e3282feebe5. PMID: 18635981. Letter; Author reply 238-9.
The publication is a letter or correspondence in which the HoMedics BPA-300 is referenced.
Ware A, Stevens R, Selwood M, Fleming S. Accuracy of blood pressure monitors available in high street pharmacies. Blood Press Monit. 2016 Feb;21(1):59-61. doi: 10.1097/MBP.0000000000000151. PMID: 26427055.
The publication describes the HoMedics BPA-300 being used as a reference device for comparison with the Alvita MC101 and the Boots 6378544.